ADMA BIOLOGICS, INC. Annual Operating Income (Loss) in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Adma Biologics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
  • Adma Biologics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $39.6M, a 356% increase year-over-year.
  • Adma Biologics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $115M, a 8471% increase year-over-year.
  • Adma Biologics, Inc. annual Operating Income (Loss) for 2023 was $21.6M.
  • Adma Biologics, Inc. annual Operating Income (Loss) for 2022 was -$39.4M, a 32.6% increase from 2021.
  • Adma Biologics, Inc. annual Operating Income (Loss) for 2021 was -$58.4M, a 10.1% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $21.6M +$61M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$39.4M +$19M +32.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$58.4M +$6.54M +10.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 -$64.9M -$23.5M -56.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 -$41.4M +$18.9M +31.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 -$60.3M -$21M -53.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 -$39.3M -$22M -127% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-13
2016 -$17.3M -$1.82M -11.7% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-29
2015 -$15.5M +$505K +3.15% Jan 1, 2015 Dec 31, 2015 10-K 2017-02-24
2014 -$16M -$976K -6.49% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-23
2013 -$15M -$7.13M -90.2% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-09
2012 -$7.91M -$3.29M -71.1% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-28
2011 -$4.62M Jan 1, 2011 Dec 31, 2011 10-K 2013-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.